0

Close
 
Upcoming Allied Market Research
2023
Lung Biopsy Devices Market

Lung Biopsy Devices Market

by Product Type (Core Needle Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Surgical Biopsy Devices, Vacuum-Assisted Biopsy Devices), by Procedure Type (Needle Biopsy, Thoracoscopic Biopsy, Transbronchial Biopsy, Open Biopsy) and by End User (Hospitals, Cancer Research Centers, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A06257
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Lung Biopsy Devices Market

Request Now !

Biopsy is a procedure to perform surgical removal of tissue from an organ to determine the presence or extent of a disease, generally cancerous and inflammatory conditions. Lung biopsyinvolves removal of lung tissues for determining any cancer, infection, or lung disease. Lung biopsy can be performed either by open lung or closed lung procedures. An open lung biopsy is carried out in operating rooms under general anesthesia by making an incision in the skin on the chest and a closed lung biopsy is also called needle biopsy that makes use of a needle for tissue removal. The closed lung biopsy is carried out through skin or trachea. The lung biopsy procedure helps the health professionals to correctly diagnose the suitable treatment for the patient. 

Lung biopsy helps in detecting the stages of cancerin patients;thus, increasing the demand for biopsies across the world as it is an important tool for diagnosis and treatment. Biopsy followed by imaging tests helps in determining whether the nodule is cancerous or non-cancerous. As per WHO, in 2018, lung cancer is responsible for the largest number of deaths approximately 1.8 million deaths across the globe because of the poor prognosis for this cancer. Lower respiratory infections remained the deadliest communicable disease, causing 3.0 million deaths worldwide in 2016.

Rise in prevalence of lung cancer in developing as well as developed countries due to adoption of unhealthy lifestyle along with increase in lung infections are anticipated to boost the demand for lung biopsy systems globally. Furthermore, technological advancements such as ultrasound technology and guidance systems like vacuum assisted guns boost the demand for lung biopsy systems in coming years. However, lack of awareness and high costs associated with lung biopsy systemsare expected to hinder the growth of the lung biopsy devices market. Moreover, risks associated with the biopsy treatment such as lesions and fissure puncturehamper the market growth. On the contrary, introduction of new cost-effective lung biopsy systems and widening base of the population associated with lung cancer are anticipated to provide lucrative opportunities for the growth of the lung biopsy devices market across the globe.

The global lung biopsy devices market is divided on the basis of product, procedure, enduser, and region. Based on product, the market is divided into core needle biopsy devices, fine needle aspiration biopsy devices, surgical biopsy devices, and vacuum-assisted biopsy devices. Based on procedure, it is segmented into needle biopsy, thoracoscopic biopsy, transbronchial biopsy, and open biopsy. By end user, the market is classified into hospitals, cancer research centers, specialty clinics, and others. Region wise, the marketis analyzed across North America, Asia-Pacific, Europe, and LAMEA.

Some of the major players operating in the market are Becton, Dickinson and Company, DTR Medical, Medtronic, Fujifilm Medical Systems, Hologic, Inc., Olympus Corporation, Argon Medical Devices, Argon Medical Devices, Inc., Cardinal Health, Inc., and B. Braun Melsungen AG.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current market trends and lung biopsy devices market forecast estimations which assists to identify the prevailing opportunities. 

  • An in-depthlung biopsy devices market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

  • A comprehensive analysis of the factors that drive and restrain the growth of the lung biopsy devices market is provided.

  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.

  • The projections in this report are made by analyzing the current lung biopsy devicesmarket trends and future market potential in terms of value.

  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

  • The key lung biopsy devices market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the lung biopsy devices market.

 Lung Biopsy Devices Market Report Highlights

Aspects Details
By Product Type
  • Core Needle Biopsy Devices
  • Fine Needle Aspiration Biopsy Devices
  • Surgical Biopsy Devices
  • Vacuum-Assisted Biopsy Devices
By Procedure Type
  • Needle Biopsy
  • Thoracoscopic Biopsy
  • Transbronchial Biopsy
  • Open Biopsy
By End User
  • Hospitals
  • Cancer Research Centers
  • Specialty Clinics
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Hologic Inc., Cardinal Health Inc., Becton Dickinson and Company, B. Braun Melsungen AG., Olympus Corporation, Argon Medical Devices, DTR Medical, Argon Medical Devices Inc., Fujifilm Medical Systems, Medtronic
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: LUNG BIOPSY DEVICES MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Core Needle Biopsy Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Fine Needle Aspiration Biopsy Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Surgical Biopsy Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Vacuum-Assisted Biopsy Devices

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: LUNG BIOPSY DEVICES MARKET, BY PROCEDURE TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Procedure Type

    • 5.2. Needle Biopsy

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Thoracoscopic Biopsy

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Transbronchial Biopsy

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Open Biopsy

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: LUNG BIOPSY DEVICES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Cancer Research Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Specialty Clinics

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: LUNG BIOPSY DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product Type

      • 7.2.3. Market Size and Forecast, By Procedure Type

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Lung Biopsy Devices Market

        • 7.2.6.1. Market Size and Forecast, By Product Type
        • 7.2.6.2. Market Size and Forecast, By Procedure Type
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Lung Biopsy Devices Market

        • 7.2.7.1. Market Size and Forecast, By Product Type
        • 7.2.7.2. Market Size and Forecast, By Procedure Type
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Lung Biopsy Devices Market

        • 7.2.8.1. Market Size and Forecast, By Product Type
        • 7.2.8.2. Market Size and Forecast, By Procedure Type
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product Type

      • 7.3.3. Market Size and Forecast, By Procedure Type

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Lung Biopsy Devices Market

        • 7.3.6.1. Market Size and Forecast, By Product Type
        • 7.3.6.2. Market Size and Forecast, By Procedure Type
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Lung Biopsy Devices Market

        • 7.3.7.1. Market Size and Forecast, By Product Type
        • 7.3.7.2. Market Size and Forecast, By Procedure Type
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Lung Biopsy Devices Market

        • 7.3.8.1. Market Size and Forecast, By Product Type
        • 7.3.8.2. Market Size and Forecast, By Procedure Type
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Lung Biopsy Devices Market

        • 7.3.9.1. Market Size and Forecast, By Product Type
        • 7.3.9.2. Market Size and Forecast, By Procedure Type
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Lung Biopsy Devices Market

        • 7.3.10.1. Market Size and Forecast, By Product Type
        • 7.3.10.2. Market Size and Forecast, By Procedure Type
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Lung Biopsy Devices Market

        • 7.3.11.1. Market Size and Forecast, By Product Type
        • 7.3.11.2. Market Size and Forecast, By Procedure Type
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Lung Biopsy Devices Market

        • 7.3.12.1. Market Size and Forecast, By Product Type
        • 7.3.12.2. Market Size and Forecast, By Procedure Type
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product Type

      • 7.4.3. Market Size and Forecast, By Procedure Type

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Lung Biopsy Devices Market

        • 7.4.6.1. Market Size and Forecast, By Product Type
        • 7.4.6.2. Market Size and Forecast, By Procedure Type
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Lung Biopsy Devices Market

        • 7.4.7.1. Market Size and Forecast, By Product Type
        • 7.4.7.2. Market Size and Forecast, By Procedure Type
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Lung Biopsy Devices Market

        • 7.4.8.1. Market Size and Forecast, By Product Type
        • 7.4.8.2. Market Size and Forecast, By Procedure Type
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Lung Biopsy Devices Market

        • 7.4.9.1. Market Size and Forecast, By Product Type
        • 7.4.9.2. Market Size and Forecast, By Procedure Type
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Lung Biopsy Devices Market

        • 7.4.10.1. Market Size and Forecast, By Product Type
        • 7.4.10.2. Market Size and Forecast, By Procedure Type
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Lung Biopsy Devices Market

        • 7.4.11.1. Market Size and Forecast, By Product Type
        • 7.4.11.2. Market Size and Forecast, By Procedure Type
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Lung Biopsy Devices Market

        • 7.4.12.1. Market Size and Forecast, By Product Type
        • 7.4.12.2. Market Size and Forecast, By Procedure Type
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Lung Biopsy Devices Market

        • 7.4.13.1. Market Size and Forecast, By Product Type
        • 7.4.13.2. Market Size and Forecast, By Procedure Type
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Lung Biopsy Devices Market

        • 7.4.14.1. Market Size and Forecast, By Product Type
        • 7.4.14.2. Market Size and Forecast, By Procedure Type
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product Type

      • 7.5.3. Market Size and Forecast, By Procedure Type

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Lung Biopsy Devices Market

        • 7.5.6.1. Market Size and Forecast, By Product Type
        • 7.5.6.2. Market Size and Forecast, By Procedure Type
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Lung Biopsy Devices Market

        • 7.5.7.1. Market Size and Forecast, By Product Type
        • 7.5.7.2. Market Size and Forecast, By Procedure Type
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Lung Biopsy Devices Market

        • 7.5.8.1. Market Size and Forecast, By Product Type
        • 7.5.8.2. Market Size and Forecast, By Procedure Type
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Lung Biopsy Devices Market

        • 7.5.9.1. Market Size and Forecast, By Product Type
        • 7.5.9.2. Market Size and Forecast, By Procedure Type
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Lung Biopsy Devices Market

        • 7.5.10.1. Market Size and Forecast, By Product Type
        • 7.5.10.2. Market Size and Forecast, By Procedure Type
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Lung Biopsy Devices Market

        • 7.5.11.1. Market Size and Forecast, By Product Type
        • 7.5.11.2. Market Size and Forecast, By Procedure Type
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Becton Dickinson And Company

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. DTR Medical

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Medtronic

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Fujifilm Medical Systems

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Hologic Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Olympus Corporation

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Argon Medical Devices

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Argon Medical Devices Inc.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Cardinal Health Inc.

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. B. Braun Melsungen AG.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LUNG BIOPSY DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL LUNG BIOPSY DEVICES MARKET FOR CORE NEEDLE BIOPSY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL LUNG BIOPSY DEVICES MARKET FOR FINE NEEDLE ASPIRATION BIOPSY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL LUNG BIOPSY DEVICES MARKET FOR SURGICAL BIOPSY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL LUNG BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED BIOPSY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL LUNG BIOPSY DEVICES MARKET, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL LUNG BIOPSY DEVICES MARKET FOR NEEDLE BIOPSY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL LUNG BIOPSY DEVICES MARKET FOR THORACOSCOPIC BIOPSY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL LUNG BIOPSY DEVICES MARKET FOR TRANSBRONCHIAL BIOPSY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL LUNG BIOPSY DEVICES MARKET FOR OPEN BIOPSY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL LUNG BIOPSY DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL LUNG BIOPSY DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL LUNG BIOPSY DEVICES MARKET FOR CANCER RESEARCH CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL LUNG BIOPSY DEVICES MARKET FOR SPECIALTY CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL LUNG BIOPSY DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL LUNG BIOPSY DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA LUNG BIOPSY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. U.S. LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 23. U.S. LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. CANADA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. CANADA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 26. CANADA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE LUNG BIOPSY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ITALY LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 41. ITALY LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 42. ITALY LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. UK LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 47. UK LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 48. UK LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. RUSSIA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 51. RUSSIA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC LUNG BIOPSY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. CHINA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. CHINA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 61. CHINA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. JAPAN LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 64. JAPAN LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. INDIA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 66. INDIA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 67. INDIA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. AUSTRALIA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 73. AUSTRALIA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. THAILAND LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 76. THAILAND LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. MALAYSIA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 79. MALAYSIA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. INDONESIA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA LUNG BIOPSY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 89. LAMEA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. BRAZIL LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 92. BRAZIL LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH AFRICA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. SAUDI ARABIA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. UAE LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 100. UAE LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 101. UAE LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. ARGENTINA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 104. ARGENTINA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. REST OF LAMEA LUNG BIOPSY DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA LUNG BIOPSY DEVICES, BY PROCEDURE TYPE, 2022-2032 ($MILLION)
  • TABLE 107. REST OF LAMEA LUNG BIOPSY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. BECTON DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 109. BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 110. BECTON DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 111. BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 112. BECTON DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. DTR MEDICAL: KEY EXECUTIVES
  • TABLE 114. DTR MEDICAL: COMPANY SNAPSHOT
  • TABLE 115. DTR MEDICAL: OPERATING SEGMENTS
  • TABLE 116. DTR MEDICAL: PRODUCT PORTFOLIO
  • TABLE 117. DTR MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. MEDTRONIC: KEY EXECUTIVES
  • TABLE 119. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 120. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 121. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 122. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. FUJIFILM MEDICAL SYSTEMS: KEY EXECUTIVES
  • TABLE 124. FUJIFILM MEDICAL SYSTEMS: COMPANY SNAPSHOT
  • TABLE 125. FUJIFILM MEDICAL SYSTEMS: OPERATING SEGMENTS
  • TABLE 126. FUJIFILM MEDICAL SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 127. FUJIFILM MEDICAL SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. HOLOGIC INC.: KEY EXECUTIVES
  • TABLE 129. HOLOGIC INC.: COMPANY SNAPSHOT
  • TABLE 130. HOLOGIC INC.: OPERATING SEGMENTS
  • TABLE 131. HOLOGIC INC.: PRODUCT PORTFOLIO
  • TABLE 132. HOLOGIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. OLYMPUS CORPORATION: KEY EXECUTIVES
  • TABLE 134. OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 135. OLYMPUS CORPORATION: OPERATING SEGMENTS
  • TABLE 136. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 137. OLYMPUS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. ARGON MEDICAL DEVICES: KEY EXECUTIVES
  • TABLE 139. ARGON MEDICAL DEVICES: COMPANY SNAPSHOT
  • TABLE 140. ARGON MEDICAL DEVICES: OPERATING SEGMENTS
  • TABLE 141. ARGON MEDICAL DEVICES: PRODUCT PORTFOLIO
  • TABLE 142. ARGON MEDICAL DEVICES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. ARGON MEDICAL DEVICES INC.: KEY EXECUTIVES
  • TABLE 144. ARGON MEDICAL DEVICES INC.: COMPANY SNAPSHOT
  • TABLE 145. ARGON MEDICAL DEVICES INC.: OPERATING SEGMENTS
  • TABLE 146. ARGON MEDICAL DEVICES INC.: PRODUCT PORTFOLIO
  • TABLE 147. ARGON MEDICAL DEVICES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. CARDINAL HEALTH INC.: KEY EXECUTIVES
  • TABLE 149. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
  • TABLE 150. CARDINAL HEALTH INC.: OPERATING SEGMENTS
  • TABLE 151. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
  • TABLE 152. CARDINAL HEALTH INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. B. BRAUN MELSUNGEN AG.: KEY EXECUTIVES
  • TABLE 154. B. BRAUN MELSUNGEN AG.: COMPANY SNAPSHOT
  • TABLE 155. B. BRAUN MELSUNGEN AG.: OPERATING SEGMENTS
  • TABLE 156. B. BRAUN MELSUNGEN AG.: PRODUCT PORTFOLIO
  • TABLE 157. B. BRAUN MELSUNGEN AG.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LUNG BIOPSY DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LUNG BIOPSY DEVICES MARKET
  • FIGURE 3. SEGMENTATION LUNG BIOPSY DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LUNG BIOPSY DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLUNG BIOPSY DEVICES MARKET
  • FIGURE 11. LUNG BIOPSY DEVICES MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. LUNG BIOPSY DEVICES MARKET FOR CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. LUNG BIOPSY DEVICES MARKET FOR FINE NEEDLE ASPIRATION BIOPSY DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. LUNG BIOPSY DEVICES MARKET FOR SURGICAL BIOPSY DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. LUNG BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED BIOPSY DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. LUNG BIOPSY DEVICES MARKET SEGMENTATION, BY BY PROCEDURE TYPE
  • FIGURE 17. LUNG BIOPSY DEVICES MARKET FOR NEEDLE BIOPSY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. LUNG BIOPSY DEVICES MARKET FOR THORACOSCOPIC BIOPSY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. LUNG BIOPSY DEVICES MARKET FOR TRANSBRONCHIAL BIOPSY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. LUNG BIOPSY DEVICES MARKET FOR OPEN BIOPSY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. LUNG BIOPSY DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. LUNG BIOPSY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. LUNG BIOPSY DEVICES MARKET FOR CANCER RESEARCH CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. LUNG BIOPSY DEVICES MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. LUNG BIOPSY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: LUNG BIOPSY DEVICES MARKET
  • FIGURE 32. Top player positioning, 2022
  • FIGURE 33. BECTON DICKINSON AND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. DTR MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. DTR MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. DTR MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. FUJIFILM MEDICAL SYSTEMS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. FUJIFILM MEDICAL SYSTEMS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. FUJIFILM MEDICAL SYSTEMS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. HOLOGIC INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. HOLOGIC INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. HOLOGIC INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. OLYMPUS CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. OLYMPUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. OLYMPUS CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. ARGON MEDICAL DEVICES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. ARGON MEDICAL DEVICES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. ARGON MEDICAL DEVICES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. ARGON MEDICAL DEVICES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. ARGON MEDICAL DEVICES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. ARGON MEDICAL DEVICES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. CARDINAL HEALTH INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. CARDINAL HEALTH INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. CARDINAL HEALTH INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. B. BRAUN MELSUNGEN AG.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. B. BRAUN MELSUNGEN AG.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. B. BRAUN MELSUNGEN AG.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Lung Biopsy Devices Market

Start reading.
This Report and over 67,132+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers